Inventor · disambiguated record
Mahavir Prashad
Also filed as: PRASHAD MAHAVIR
30 granted patents·14 pending applications·358 citations·filing 1987–2024
97Inventor score
Top patents by PatentIndex Score
44 records- 0196US8877938B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2006·Granted Nov 4, 2014·44 cites·14 claims
- 0296US6197798B1Amino-benzocycloalkane derivativesNOVARTIS AG·Filed 1999·Granted Mar 6, 2001·108 cites·16 claims
- 0391US8008504B2Process for the synthesis of organic compoundsNOVARTIS AG·Filed 2010·Granted Aug 30, 2011·6 cites·2 claims
- 0491US2025339395A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2024·Application pending·0 cites
- 0588US8008263B2Organic compounds and their usesNOVARTIS AG·Filed 2008·Granted Aug 30, 2011·12 cites·17 claims
- 0688US7781597B2Process for the synthesis of organic compoundsNOVARTIS AG·Filed 2006·Granted Aug 24, 2010·6 cites·13 claims
- 0788US5606053AProcess for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecaneJOHNSON MATTHEY PLC·Filed 1995·Granted Feb 25, 1997·41 cites·19 claims
- 0887US5412137AProcess for preparing phosphinyloxy propanaminium inner salt derivativesSANDOZ LTD·Filed 1994·Granted May 2, 1995·36 cites·8 claims
- 0986US9388134B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2014·Granted Jul 12, 2016·5 cites·15 claims
- 1085US8222425B2Organic compounds and their usesBRITT SHAWN D·Filed 2011·Granted Jul 17, 2012·12 cites·5 claims
- 1184US11642329B2Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Granted May 9, 2023·0 cites·2 claims
- 1283US2022257551A1Amorphous solid form of compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Application pending·0 cites
- 1381US11096918B2Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 1481US8349852B2Quinazolinone derivatives useful as vanilloid antagonistsNOVARTIS AG·Filed 2010·Granted Jan 8, 2013·9 cites·5 claims
- 1579US2021361610A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2021·Application pending·0 cites
- 1677US6100401AProcess for preparing the d-threo isomer of methylphenidate hydrochlorideNOVARTRIS AG·Filed 1998·Granted Aug 8, 2000·26 cites·16 claims
- 1775US6933410B2Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amineNOVARTIS AG·Filed 2003·Granted Aug 23, 2005·8 cites·19 claims
- 1874US6162919AProcess for preparing the d-threo isomer of methylphenidate hydrochlorideNOVARTIS AG·Filed 1998·Granted Dec 19, 2000·17 cites·38 claims
- 1972US2019374498A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2072US2019374497A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2170US10668035B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2019·Granted Jun 2, 2020·1 cites·21 claims
- 2270US7452999B2Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compoundsNOVARTIS AG·Filed 2004·Granted Nov 18, 2008·4 cites·6 claims
- 2369US9802931B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2016·Granted Oct 31, 2017·1 cites·8 claims
- 2469US2018344679A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2567US9365565B2Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereofMARTERER WOLFGANG·Filed 2012·Granted Jun 14, 2016·2 cites·16 claims
- 2664US8829194B2Crystalline forms of the sodium salt of (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acidSUTTON PAUL ALLEN·Filed 2011·Granted Sep 9, 2014·1 cites·17 claims
- 2762US11426375B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·26 claims
- 2862US2016324821A1Compounds containing s-n-valeryl-n--valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2016·Application pending·0 cites
- 2958US10421755B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2017·Granted Sep 24, 2019·0 cites·13 claims
- 3057US7589216B2Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediatesNOVARTIS AG·Filed 2003·Granted Sep 15, 2009·2 cites·9 claims
- 3156US2009131707A1Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 3249US5596094AProcess for preparing 2' -0- alkyl adenosine derivativesSANDOZ LTD·Filed 1995·Granted Jan 21, 1997·6 cites·8 claims
- 3348US2009247581A1Organic CompoundsPRASHAD MAHAVIR·Filed 2006·Application pending·0 cites
- 3448US2008300410A1Organic CompoundsPRASHAD MAHAVIR·Filed 2006·Application pending·0 cites
- 3547US2014343102A1Crystalline forms of the sodium salt of (4--cyclohexyl)-acetic acidSUTTON PAUL ALLEN·Filed 2014·Application pending·0 cites
- 3643US4868319AProcess for the preparation of monoalkylcarbamate group-containing compoundsSANDOZ PHARMACEUTICALS CORP·Filed 1987·Granted Sep 19, 1989·2 cites·52 claims
- 3741US6043365APreparation of 2-amino-7-(1-substituted-2-hydroxyethyl)-3, 5-dihydropyrrolo[3,2-d]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Mar 28, 2000·4 cites·14 claims
- 3840US8258128B2Organic compoundsBOLLINGER PIETRO·Filed 2007·Granted Sep 4, 2012·0 cites·15 claims
- 3940US7915264B2Fused pyridine derivatives for use as vanilloid receptor antagonists for treating painNOVARTIS AG·Filed 2002·Granted Mar 29, 2011·0 cites·6 claims
- 4038US5691304AImproved process for preparing polymyxin B/dextran conjugatesCIBA GEIGY AG·Filed 1995·Granted Nov 25, 1997·4 cites·23 claims
- 4137US2012302756A1Process for synthesis of 2-substituted pyrrolidines and piperadinesLELETI RAJENDER REDDY·Filed 2011·Application pending·0 cites
- 4236US2013060029A1Quinazolinone derivatives useful as vanilloid antagonistsCHEN WEICHUN·Filed 2012·Application pending·0 cites
- 4331US2011112121A1Pharmaceutical Compositions and Solid FormsBERGHAUSEN JOERG·Filed 2010·Application pending·0 cites
- 4427US6107293ATachykinin antagonistsNOVARIS AG·Filed 1997·Granted Aug 22, 2000·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Mahavir Prashad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →